---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-038003"
form_type: "8-K"
ticker: "XTNT"
cik: "0001453593"
company_name: "Xtant Medical Holdings, Inc."
filed_at: "2023-10-23T23:59:59+00:00"
generated_at: "2026-06-09T16:32:11.784366+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Xtant Medical acquires nanOss production ops from RTI Surgical for $2M cash plus contingent payments

## Summary
- Acquired equipment and inventory from RTI Surgical's synthetic bone graft business for $2M cash plus contingent payments based on future nanOss product sales.
- Assumed lease for the nanOss production facility in Greenville, NC.
- Previously acquired nanOss distribution rights and IP from Surgalign in August 2023.
- CEO Sean Browne says full control will revive and grow nanOss, improving manufacturing capabilities and cash flows.

## SEC filing metadata
- accession: 0001493152-23-038003
- form_type: 8-K
- ticker: XTNT
- cik: 0001453593
- company_name: Xtant Medical Holdings, Inc.
- filed_at: 2023-10-23T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1453593/000149315223038003/0001493152-23-038003-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1453593/000149315223038003/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-038003
- JSON: https://secwatch.observer/filing/0001493152-23-038003.json
- Plain text: https://secwatch.observer/filing/0001493152-23-038003.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.